Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell ...

Longevity research has propelled the scientific community to concentrate on interventions that do more than simply add years to life ...

Biogen Inc. ( NASDAQ: BIIB) Stifel 2025 Virtual CNS Forum Conference March 18, 2025 10:15 AM ET Great. Good morning, everybody. Happy to be moderating my annual panel where Priya has to listen to me ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Hydrocortisone and testosterone are just two of 13 drugs and supplements that could lessen the impact of genes that ...

In a new study reported in Science Advances, scientists analyzed MRI data stored at the UK Biobank and identified seven genes ...

COVID-19 affects hundreds of millions of people worldwide and is often associated with long-term neurological abnormalities.

New research reveals that visceral adipose tissue helps maintain brain-derived neurotrophic factor (BDNF) levels, but this ...

Johnson & Johnson is dropping a partnership with Genmab centered around a CD38 monoclonal antibody, prompting the latter company to discontinue development of the program. Back in 2019 ...

Researchers discovered distinct molecular differences in how the brain processes directly experienced versus witnessed trauma -- a finding that could lead to more targeted treatments for PTSD.

While the initial HexaBody-CD38 clinical data is promising and showed robust clinical efficacy, following a thorough evaluation of the data, the market landscape, and Genmab’s rigorous portfolio ...